Northwestern Medicine

Regarding acceptable risk thresholds, Alam describes himself as relatively risk-averse, favoring a 5% to 10% miss rate for Grade Group 2 or higher disease when considering biopsy avoidance.

Alam frames PHI and MRI as noninvasive tools that help refine risk before proceeding to biopsy.

Jennifer Miles-Thomas, MD, URPS, MBA, emphasizes that teleurology and team-based care models offer significant promise

The study retrospectively analyzed 456 biopsy-naive men who underwent PHI testing followed by a prostate biopsy.

2025 featured multiple advancements in women's health aimed at enhancing treatment options and awareness.

Nicholas Deebel, MD, shared key takeaways from a recent review outlining the current evidence on post-vasectomy pain syndrome.

Data suggested that most patients do not have a preference on the gender of the urologist who is providing their vasectomy care.

Joshua J. Meeks, MD, PhD, highlights that collaboration between urologists and medical oncologists has become essential.

Amy E. Krambeck, MD, explained that active suction provided by FANS helps reduce intrarenal pressure by continuously removing irrigation fluid.

Krambeck highlights that FANS combine enhanced maneuverability and effective fragment evacuation, leading to higher stone clearance rates and improved procedural outcomes in endourology.

Krambeck pointed to the growing importance of medical management in stone disease prevention.

Several experts share their thoughts on the impact of the gemcitabine intravesical system for BCG-unresponsive NMIBC.

Miles-Thomas emphasized the importance of Northwestern’s thoughtful implementation strategy.

Both urologists emphasized that Northwestern’s integrated structure and commitment to innovation allow any urologist within the network to contribute ideas and see them developed into practice.

The course addresses "unicorn cases" in the upper tract—unique and challenging situations lacking established guidelines or literature.

Amy E. Krambeck, MD, discusses how to define success and how to determine the optimal timing for adding on a new partner.

“The takeaway is that on a population level, on a health care system perspective, it's more cost-effective and safer to do transperineal prostate biopsy,” says Mitchell M. Huang, MD.

Amir S. Patel, MD, discusses interim findings from a randomized controlled trial of onabotulinumtoxinA injection at the time of HoLEP vs standard treatment.

The risk of stricture formation was 4.6% in the TFL cohort vs 2.4% in the holmium laser cohort.

Recent data suggest that obesity may be a risk factor for increased pain on transperineal biopsy.

Amy E. Krambeck, MD, recaps her talk from AUA 2025.

"It’s a very good time to be taking care of patients with bladder cancer," says Joshua J. Meeks, MD, PhD.

Jennifer Miles-Thomas, MD, URPS, MBA, discusses the AUA's legislative priorities along with issues in medicine related to artificial intelligence.

“It's going to be an important time for US urologists to identify that this is becoming the standard of care," says Joshua J. Meeks, MD, PhD.

“You absolutely need to have a CT scan prior to the surgery to best identify and really intimately understand the kidney’s anatomy," says Perry Xu, MD.

"There really wasn't a difference in in surgical outcomes. The patients tolerated it very well,” says Joshua J. Meeks, MD, PhD.

“The NIAGARA approval really begins to bring immunotherapy into the neoadjuvant setting," says Joshua J. Meeks, MD, PhD.

"A lot of people are using [single-use ureteroscopes] nowadays, and part of it is because it really enhances our ability to provide guaranteed care, because we don't have to rely on the reusability of scopes," says Perry Xu, MD.

“I think we can really use AI in several different facets of endourology," says Perry Xu, MD.